All clinical trials must be reported in detail and made publicly available

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7466.626-a (Published 09 September 2004) Cite this as: BMJ 2004;329:626
  1. Toshi A Furukawa, professor (furukawa@med.nagoya-cu.ac.jp)
  1. Department of Psychiatry, Nagoya City University Medical School, Mizuho-cho, Mizuho-ku, Nagoya 467-8601 Japan

    EDITOR—It is usually only the regulatory agencies, such as the Food and Drug Administration, that have access to clinical trials data submitted from pharmaceutical companies, as described by Lenzer for selective serotonin reuptake inhibitors in children.1 However, the situation is now different for paroxetine. Full reports of its clinical trials are available on the internet,2 and we can …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription